![Christopher J. Barden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Christopher J.
Barden is the founder of DeNovaMed, Inc. and holds the title of Director.
DeNovaMed, Inc. was founded in 2006.
Dr. Barden is the founder of Treventis Corp.
and holds the title of Chief Executive Officer.
Christopher J. Barden active positions
| Companies | Position | Start |
|---|---|---|
Treventis Corp.
 Treventis Corp. BiotechnologyHealth Technology Develops a small molecule drugs for Alzheimer’s and other protein misfolding diseases | Chief Executive Officer | - |
DeNovaMed, Inc.
 DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology Develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs | Founder | 01/01/2006 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Treventis Corp.
Treventis Corp. BiotechnologyHealth Technology Develops a small molecule drugs for Alzheimer’s and other protein misfolding diseases | Health Technology |
DeNovaMed, Inc.
DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology Develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs | Health Technology |
- Stock Market
- Insiders
- Christopher J. Barden
